Log in

ASX:EMV - EMvision Medical Devices Stock Price, Forecast & News

0.00 (0.00 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
Now: A$0.90
50-Day Range
MA: A$0.80
52-Week Range
Now: A$0.90
Volume118,337 shs
Average VolumeN/A
Market Capitalization$51.53 million
P/E RatioN/A
Dividend YieldN/A
EMvision Medical Devices Limited focuses on developing and commercializing medical imaging devices using electromagnetic microwave imaging for diagnosing stroke and other medical applications in Europe and Australia. It intends to offer brain scanner, a portable clinical prototype that utilizes the EMvision technology to create three dimensional images of the human brain. EMvision Medical Devices Limited has a strategic collaboration with Keysight Technologies Malaysia Sdn Bhd to develop a personalized vector network analysis solution for medical imaging in the healthcare sector. The company was founded in 2017 and is based in Brisbane, Australia.

Industry, Sector and Symbol

Industry Medical Devices
Phone61 2 8667 5337



Sales & Book Value

Annual Sales$1.41 million
Cash FlowA$0.08 per share
Book ValueA$0.08 per share



Market Cap$51.53 million
Next Earnings DateN/A
OptionableNot Optionable

Receive EMV News and Ratings via Email

Sign-up to receive the latest news and ratings for EMV and its competitors with MarketBeat's FREE daily newsletter.

EMvision Medical Devices (ASX:EMV) Frequently Asked Questions

What is EMvision Medical Devices' stock symbol?

EMvision Medical Devices trades on the ASX under the ticker symbol "EMV."

How were EMvision Medical Devices' earnings last quarter?

EMvision Medical Devices Ltd (ASX:EMV) posted its quarterly earnings results on Tuesday, February, 26th. The company reported ($4.47) EPS for the quarter. View EMvision Medical Devices' Earnings History.

Has EMvision Medical Devices been receiving favorable news coverage?

Press coverage about EMV stock has trended somewhat negative recently, InfoTrie reports. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. EMvision Medical Devices earned a news sentiment score of -1.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for EMvision Medical Devices.

Who are some of EMvision Medical Devices' key competitors?

Who are EMvision Medical Devices' key executives?

EMvision Medical Devices' management team includes the folowing people:
  • Mr. John Keep, Exec. Chairman
  • Dr. Ronald Peter Weinberger, Chief Exec. Officer
  • Ms. Emma Waldon, CFO & Company Sec. (Age 43)
  • Mr. Scott Kirkland, Exec. Director

What is EMvision Medical Devices' stock price today?

One share of EMV stock can currently be purchased for approximately A$0.90.

How big of a company is EMvision Medical Devices?

EMvision Medical Devices has a market capitalization of $51.53 million and generates $1.41 million in revenue each year. View Additional Information About EMvision Medical Devices.

What is EMvision Medical Devices' official website?

The official website for EMvision Medical Devices is http://www.emvision.com.au/.

How can I contact EMvision Medical Devices?

The company can be reached via phone at 61 2 8667 5337.

MarketBeat Community Rating for EMvision Medical Devices (ASX EMV)

Community Ranking:  4.4 out of 5 (star star star star)
Outperform Votes:  98 (Thanks for Voting!)
Underperform Votes:  14 (Thanks for Voting!)
Total Votes:  112
MarketBeat's community ratings are surveys of what our community members think about EMvision Medical Devices and other stocks. Vote "Outperform" if you believe EMV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EMV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: Risk Tolerance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel